Prostate cancer: a presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy

by Mayen T Grageda, Bonnie Choy, Gladell P Paner, Jeffrey S So
Published 2021-01-01

Perineal dermoid cyst in a young male

by Matthew Sloan, Richard J. Fantus, Gladell P. Paner, Sarah Faris
Published 2020-11-01

Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer

by Ragheed Saoud, Nassib Abou Heidar, Alessia Cimadamore, Gladell P. Paner
Published 2020-09-01

Transurethral resection and surveillance of a well-differentiated neuroendocrine tumor in a ileal neobladder

by Audry Kang, Brittany Adamic, Caleb A. Cooper, Gladell P. Paner, Ryan P. Werntz
Published 2020-09-01

Sustained complete response to cytotoxic therapy and the PARP inhibitor veliparib in metastatic castration resistant prostate cancer – a case report

by David J VanderWeele, Gladell P Paner, Gini F Fleming, Russell Z Szmulewitz
Published 2015-07-01

Sox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancer.

by Steven Kregel, Kyle J Kiriluk, Alex M Rosen, Yi Cai, Edwin E Reyes, Kristen B Otto, Westin Tom, Gladell P Paner, Russell Z Szmulewitz, Donald J Vander Griend
Published 2013-01-01